Laveena Munshi

Laveena Munshi

Auto-generated profile, based on publicly available information

Laveena Munshi

Interdepartmental Division of Critical Care Medicine, Sinai Health System/University Health Network, University of Toronto, Toronto, Canada

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
NQNida Qadir
Nida Qadir
SSSarina Sahetya
Sarina Sahetya
LMLaveena Munshi
Laveena Munshi
CSCharlotte Summers
Charlotte Summers
DADarryl Abrams
Darryl Abrams
EFEddy Fan
Eddy Fan
Background: This document updates previously published Clinical Practice Guidelines for the management of patients with acute respiratory distress syndrome (ARDS), incorporating new evidence addressing the use of corticosteroids, venovenous extracorporeal membrane oxygenation, neuromuscular blocking agents, and positive end-expiratory pressure (PEEP). Methods: We summarized evidence addressing four “PICO questions” (patient, intervention, comparison, and outcome). A multidisciplinary panel with expertise in ARDS used the Grading of Recommendations, Assessment, Development, and Evaluation framework to develop clinical recommendations. Results: We suggest the use of: 1) corticosteroids for patients with ARDS (conditional recommendation, moderate certainty of evidence), 2) venovenous extracorporeal membrane oxygenation in selected patients with severe ARDS (conditional recommendation, low certainty of evidence), 3) neuromuscular blockers in patients with early severe ARDS (conditional recommendation, low certainty of evidence), and 4) higher PEEP without lung recruitment maneuvers as opposed to lower PEEP in patients with moderate to severe ARDS (conditional recommendation, low to moderate certainty), and 5) we recommend against using prolonged lung recruitment maneuvers in patients with moderate to severe ARDS (strong recommendation, moderate certainty). Conclusions: We provide updated evidence-based recommendations for the management of ARDS. Individual patient and illness characteristics should be factored into clinical decision making and implementation of these recommendations while additional evidence is generated from much-needed clinical trials.

1 February 2019 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
LMLaveena Munshi
Laveena Munshi
AWAllan Walkey
Allan Walkey
EGEwan Goligher
Ewan Goligher
TPTai Pham
Tai Pham
EUElizabeth M Uleryk
Elizabeth M Uleryk
EFEddy Fan
Eddy Fan

6 September 2024 in Journal of Critical Care
Verified
Journal Article
Open access
SDStephan von Düring
Stephan von Düring
KPKen Kuljit S. Parhar
Ken Kuljit S. Parhar
NANeill Adhikari
Neill Adhikari
MUMartin Urner
Martin Urner
SKS. Joseph Kim
S. Joseph Kim
EFEddy Fan
Eddy Fan
Mechanical ventilation stands as a life-saving intervention in the management of respiratory failure. However, it carries the risk of ventilator-induced lung injury. Despite the adoption of lung-protective ventilation strategies, including lower tidal volumes and pressure limitations, mortality rates remain high, leaving room for innovative approaches. The concept of mechanical power has emerged as a comprehensive metric encompassing key ventilator parameters associated with the genesis of ventilator-induced lung injury, including volume, pressure, flow, resistance, and respiratory rate. While numerous animal and human studies have linked mechanical power and ventilator-induced lung injury, its practical implementation at the bedside is hindered by calculation challenges, lack of equation consensus, and the absence of an optimal threshold. To overcome the constraints of measuring static respiratory parameters, dynamic mechanical power is proposed for all patients, regardless of their ventilation mode. However, establishing a causal relationship is crucial for its potential implementation, and requires further research. The objective of this review is to explore the role of mechanical power in ventilator-induced lung injury, its association with patient outcomes, and the challenges and potential benefits of implementing a ventilation strategy based on mechanical power.

7 October 2019 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
OIOn behalf of the Nine-i Investigators
On behalf of the Nine-i Investigators
EAElie Azoulay
Elie Azoulay
PBPhilippe R. Bauer
Philippe R. Bauer
ÉMÉric Mariotte
Éric Mariotte
LRLene Russell
Lene Russell
ALAndry Van De Louw
Andry Van De Louw

18 December 2020 in Canadian Medical Association Journal
Verified
Journal Article
Open access
PDF file
LMLaveena Munshi
Laveena Munshi
GEGerald Evans
Gerald Evans
FRFahad Razak
Fahad Razak

13 January 2020 in Critical Care
Verified
Journal Article
Open access
PDF file
SFShannon M. Fernando
Shannon M. Fernando
RMRebecca Mathew
Rebecca Mathew
BHBenjamin Hibbert
Benjamin Hibbert
BRBram Rochwerg
Bram Rochwerg
LMLaveena Munshi
Laveena Munshi
KKKwadwo Kyeremanteng
Kwadwo Kyeremanteng
Background: New-onset atrial fibrillation (NOAF) is commonly encountered in critically ill adults. Evidence evaluating the association between NOAF and patient-important outcomes in this population is conflicting. Furthermore, little is known regarding the association between NOAF and resource use or hospital costs. Methods: Retrospective analysis (2011–2016) of a prospectively collected registry from two Canadian hospitals of consecutive ICU patients aged ≥ 18 years. We excluded patients with a known history of AF prior to hospital admission. Any occurrence of atrial fibrillation (AF) was prospectively recorded by bedside nurses. The primary outcome was hospital mortality, and we used multivariable logistic regression to adjust for confounders. We used a generalized linear model to evaluate contributors to total cost. Results: We included 15,014 patients, and 1541 (10.3%) had NOAF during their ICU admission. While NOAF was not associated with increased odds of hospital death among the entire cohort (adjusted odds ratio [aOR] 1.02 [95% confidence interval [CI] 0.97–1.08]), an interaction was noted between NOAF and sepsis, and the presence of both was associated with higher odds of hospital mortality (aOR 1.28 [95% CI 1.09–1.36]) than either alone. Patients with NOAF had higher total costs (cost ratio [CR] 1.09 [95% CI 1.02–1.20]). Among patients with NOAF, treatment with a rhythm-control strategy was associated with higher costs (CR 1.24 [95% CI 1.07–1.40]). Conclusions: While NOAF was not associated with death or requiring discharge to long-term care among critically ill patients, it was associated with increased length of stay in ICU and increased total costs.